1. Home
  2. NEO vs CIM Comparison

NEO vs CIM Comparison

Compare NEO & CIM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo NeoGenomics Inc.

NEO

NeoGenomics Inc.

HOLD

Current Price

$7.90

Market Cap

1.2B

Sector

Health Care

ML Signal

HOLD

Logo Chimera Investment Corporation

CIM

Chimera Investment Corporation

HOLD

Current Price

$13.11

Market Cap

1.1B

Sector

Real Estate

ML Signal

HOLD

Company Overview

Basic Information
Metric
NEO
CIM
Founded
2001
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Precision Instruments
Real Estate Investment Trusts
Sector
Health Care
Real Estate
Exchange
Nasdaq
Nasdaq
Market Cap
1.2B
1.1B
IPO Year
2008
N/A

Fundamental Metrics

Financial Performance
Metric
NEO
CIM
Price
$7.90
$13.11
Analyst Decision
Buy
Buy
Analyst Count
7
2
Target Price
$11.14
$15.25
AVG Volume (30 Days)
2.0M
830.4K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
11.25%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$10.63
N/A
Revenue Next Year
$9.73
$3.65
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$4.72
$9.85
52 Week High
$13.74
$14.88

Technical Indicators

Market Signals
Indicator
NEO
CIM
Relative Strength Index (RSI) 19.28 42.85
Support Level $7.07 $12.93
Resistance Level $8.89 $13.19
Average True Range (ATR) 0.47 0.30
MACD -0.11 -0.08
Stochastic Oscillator 2.30 0.49

Price Performance

Historical Comparison
NEO
CIM

About NEO NeoGenomics Inc.

NeoGenomics Inc provides oncology diagnostic testing and consultative services which include technical laboratory services and professional interpretation of laboratory test results by licensed physicians or molecular experts in pathology and oncology. The company operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. The company operates in a single segment and derives revenue from clients by providing clinical cancer testing, interpretation, and consultative services, molecular and NGS testing, comprehensive technical and professional services offerings, clinical trials and research, validation laboratory services, and oncology data solutions.

About CIM Chimera Investment Corporation

Chimera Investment Corporation is a real estate investment trust engaged in investing in a portfolio of mortgage assets on a leveraged basis. These investments include a variety of government-sponsored agency residential mortgage-backed securities, or RMBS, non-agency RMBS, agency commercial mortgage-backed securities, residential mortgage loans, and other real estate-related securities. Agency mortgage-backed securities represent the share of this portfolio, while subprime residential mortgage loans and non-agency RMBS also make up substantial shares.

Share on Social Networks: